Worldwide Heart Valve Market Report: 2009 Edition

The two major segments of heart valve market – tissue valve & mechanical valve – both have pros and cons. Tissue valves have a lower risk for clotting but they are not durable for long-term usage compared to mechanical valves. Mechanical valves are more durable, but require anti-coagulant drugs to prevent blood clots. Tissue valve are ideal for older patients.

The mechanical valve market is expected to continue to grow in the low single digits while tissue valve market is growing at mid-single digit rates. Global mechanical valve unit sales have declined significantly over the last five years due to growth of tissue valves. Overall growth would be driven by the expansion of cardiac surgery in countries such as China, India and Eastern European nations.

Edwards Life Sciences is the leader in global tissue valve market while in the mechanical valve segment, St. Jude Medical is the global market leader. Heart valve companies are targeting the transcatheter valve segment, which presents an attractive market opportunity. The technology, involving less invasive approach, is ideal for high risk patients. In the long-term, transcatheter valves are expected to represent an increasing share of the heart valve market.
[Studien Infos ausblenden]

1. Heart Valves: An Overview

Market Segments

2. Market Size

Global Market Value
Global Market Share
Mechanical Valves
Tissue Valves
Valve Repair Segment
US Market

3. Market Trends

3.1 Low Penetration in Aortic Stenosis Market
3.2 Opportunity in Transcatheter Valves
3.3 Mitral Regurgitation
3.4 Huge Expenditure on Cardiovascular Diseases
3.5 Demographic Trends in Cardiovascular Diseases
3.6 Stem Cells to Build New Heart Valves
3.7 Significant Share of Untreated Patients

4. Company Profiles

4.1 Medtronic

Overview
Business Strategies
Diversification Strategy
AF & Transcatheter Valve Business
Marketing & Sales Strategy

4.2 St. Jude Medical

Overview
Business Strategies
Penetrating High-growth Segments of Medical Devices Market
Robust AF Platform

4.3 Edwards Lifesciences

Overview
Business Strategies
Divestment of Non-core Assets
Dual Path Strategy
Trancatheter Valve Business

4.4 Sorin Group

Overview
Business Strategies
Robust Product Pipeline
Financial Strength

5. Industry Outlook

5.1 Market Forecast

5.2 Forecast Methodology

5.2.1 Dependent and Independent Variables
5.2.2 Correlation Analysis
5.2.3 Regression Analysis

7. Market Forecast
[Inhaltsverzeichnis ausblenden]

US Heart Valve Market by Value (2005-12)
US Heart Valve Market by Volume (2005-12)
Estimated Direct/Indirect Costs of CVD/Stroke in US (2009E)
Dependent & Independent Variables (2002– 2008)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

Heart Valve Market Segmentation
Global Heart Valve Market (2006-08E)
Global Heart Valve Market Share (2006-10E)
Surgical Valve Repair & Replacement Sales – Worldwide Market Share (2003-08)
Global Mechanical Valves Market Share (2007-12E)
Global Tissue Valves Market Share (2007-12E)
Surgical Valve Repair & Replacement Sales – US Market Share (2008)
Surgical Valve Repair & Replacement Sales – Europe Market Share (2008)
Aortic Stenosis Prevalence in US by Age (2007)
Type of Aortic Stenosis Prevalence in US by Age (2007)
Mitral Regurgitation Analysis in US (2007)
Prevalence of Cardiovascular Diseases by Age/Gender in US (2006)
Cardiovascular Market in US – Treated/Untreated by Therapy (2007)
Medtronic - Revenue by Business Segment (2008)
St. Jude Medical - Revenue by Business Segment (2008)
Edwards Lifesciences - Revenue by Business Segment (2008)
Sorin - Revenue by Business Segment (2008)
Heart Valve Market Forecast (2009-11E)
[Tabellenverzeichnis ausblenden]